Mitochondrial Dysfunction in Dopaminergic Neurons and the Impact on Neurodegeneration in Parkinson's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Köln, Universität zu Köln, Dissertation, 2020
- Schlagwort
-
Dopaminergic neurons
Impact
Parkinson's disease
- Ereignis
-
Veröffentlichung
- (wo)
-
Köln
- (wer)
-
Universitäts- und Stadtbibliothek Köln
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
-
Kloppenburg, Peter
Trifunovic, Aleksandra
Rugarli, Elena
Wiesner, Rudolf
- URN
-
urn:nbn:de:hbz:38-121302
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Paß, Thomas
- Kloppenburg, Peter
- Trifunovic, Aleksandra
- Rugarli, Elena
- Wiesner, Rudolf
- Universitäts- und Stadtbibliothek Köln
Entstanden
- 2020
Ähnliche Objekte (12)
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease
Modeling ferroptosis in human dopaminergic neurons : Pitfalls and opportunities for neurodegeneration research
Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease
Modeling ferroptosis in human dopaminergic neurons : Pitfalls and opportunities for neurodegeneration research
Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson’s disease patients
Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease
Modeling ferroptosis in human dopaminergic neurons : Pitfalls and opportunities for neurodegeneration research
Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease